Roger R Gomis

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 23

Top Venues

Nature communications

Cell death & disease

Nature cell biology

Cancer research

Institute for Research in Biomedicine (IRB Barcleona)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Research in Biomedicine (IRB Barcleona)

Spain

ICREA Research Professor I Group Leader :: Oncology

Publications

Jana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, Jon Corres-Mendizabal, Onintza Carlevaris, Ianire Astobiza, Amaia Zabala-Letona, Marc Guiu, Mikel Azkargorta, Monika Gonzalez-Lopez, Nuria Macías-Cámara, Phuong Doan, Félix Elortza, Isabel Mendizabal, Jukka Westermarck, Roger R Gomis, Amaia Ercilla, Arkaitz Carracedo
The PP2A regulator IER5L supports prostate cancer progression. Cell death & disease 15 (7) (2024)
Jana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, Jon Corres-Mendizabal, Onintza Carlevaris, Ianire Astobiza, Amaia Zabala-Letona, Marc Guiu, Mikel Azkargorta, Monika Gonzalez-Lopez, Nuria Macías-Cámara, Phuong Doan, Félix Elortza, Isabel Mendizabal, Jukka Westermarck, Roger R Gomis, Amaia Ercilla, Arkaitz Carracedo
The PP2A regulator IER5L supports prostate cancer progression. Cell death & disease 15 (7) (2024)
Jana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, Jon Corres-Mendizabal, Onintza Carlevaris, Ianire Astobiza, Amaia Zabala-Letona, Marc Guiu, Mikel Azkargorta, Monika Gonzalez-Lopez, Nuria Macías-Cámara, Phuong Doan, Félix Elortza, Isabel Mendizabal, Jukka Westermarck, Roger R Gomis, Amaia Ercilla, Arkaitz Carracedo
The PP2A regulator IER5L supports prostate cancer progression. Cell death & disease 15 (7) (2024)
Jana R Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, Jon Corres-Mendizabal, Onintza Carlevaris, Ianire Astobiza, Amaia Zabala-Letona, Marc Guiu, Mikel Azkargorta, Monika Gonzalez-Lopez, Nuria Macías-Cámara, Phuong Doan, Félix Elortza, Isabel Mendizabal, Jukka Westermarck, Roger R Gomis, Amaia Ercilla, Arkaitz Carracedo
The PP2A regulator IER5L supports prostate cancer progression. Cell death & disease 15 (7) (2024)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Alicia Llorente, María Teresa Blasco, Irene Espuny, Marc Guiu, Cecilia Ballaré, Enrique Blanco, Adrià Caballé, Anna Bellmunt, Fernando Salvador, Andrea Morales, Marc Nuñez, Guillem Loren, Francesca Imbastari, Marta Alves Fidalgo, Cristina Figueras-Puig, Patrizia Gibler, Mariona Graupera, Freddy Monteiro, Antoni Riera, Ingunn Holen, Alexandra Avgustinova, Luciano Di Croce, Roger R Gomis
MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis. Nature cell biology (2023)
Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández-Prat, David Casadevall, Silvia Menendez, Daniel Dan Liu, Minhong Shen, Jordi Berenguer, Irene Rius Ruiz, Raul Peña, José Carlos Montañés, M Mar Albà, Sarah Bonnin, Julia Ponomarenko, Roger R Gomis, Juan Miguel Cejalvo, Sonia Servitja, Diego M Marzese, Lluis Morey, Leonie Voorwerk, Joaquín Arribas, Begoña Bermejo, Marleen Kok, Lajos Pusztai, Yibin Kang, Joan Albanell, Toni Celià-Terrassa
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. Nature cancer 3 (3) (2022)
Elisa I Rivas, Jenniffer Linares, Melissa Zwick, Andrea Gómez-Llonin, Marc Guiu, Anna Labernadie, Jordi Badia-Ramentol, Anna Lladó, Lídia Bardia, Iván Pérez-Núñez, Carolina Martínez-Ciarpaglini, Noelia Tarazona, Anna Sallent-Aragay, Marta Garrido, Toni Celià-Terrassa, Octavio Burgués, Roger R Gomis, Joan Albanell, Alexandre Calon
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors. Nature communications 13 (1) (2022)
Josep Tarragó-Celada, Carles Foguet, Míriam Tarrado-Castellarnau, Silvia Marín, Xavier Hernandez-Alias, Jordi Perarnau, Fionnuala Morrish, David Hockenbery, Roger R Gomis, Eytan Ruppin, Mariia Yuneva, Pedro de Atauri, Marta Cascante
Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer. Cancers 13 (3) (2021)
Alexander H G Paterson, Peter C Lucas, Stewart J Anderson, Eleftherios P Mamounas, Adam M Brufsky, Luis Baez-Diaz, Karen M King, Thomas Lad, André Robidoux, Melanie Finnigan, Miguel Sampayo, Juan Carlos Tercero, Joël Jean Mairet, Antonio C Wolff, Louis Fehrenbacher, Norman Wolmark, Roger R Gomis
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice. JNCI cancer spectrum 5 (4) (2021)
María Teresa Blasco, Roger R Gomis
PD-L1 controls cancer pyroptosis. Nature cell biology 22 (10) (2020)
Jelena Urosevic, María Teresa Blasco, Alicia Llorente, Anna Bellmunt, Antoni Berenguer Llergo, Marc Guiu, Adrià Cañellas, Esther Fernandez, Ivan Burkov, Maria Clapés, Mireia Cartanà, Cristina Figueras-Puig, Eduard Batlle, Angel R Nebreda, Roger R Gomis
ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer. Cancer research 80 (21) (2020)
Fara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, Laia Paré, Paolo G Nuciforo, Antonio Llombart-Cussac, Begoña Bermejo, Mafalda Oliveira, Serafín Morales, Noelia Martínez, Maria Vidal, Barbara Adamo, Adrienne G Waks, Sonia Pernas, Rafael López, Montserrat Muñoz, Núria Chic, Patricia Galván, Isabel Garau, Luis Manso, Jesús Alarcón, Eduardo Martínez, Sara Gregorio, Roger R Gomis, Patricia Villagrasa, Javier Cortés, Eva Ciruelos, Aleix Prat
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade. Nature communications 11 (1) (2020)
Fernando Salvador, Alicia Llorente, Roger R Gomis
From latency to overt bone metastasis in breast cancer: potential for treatment and prevention. The Journal of pathology 249 (1) (2019)
Saška Ivanova, Mira Polajnar, Alvaro Jesus Narbona-Perez, Maria Isabel Hernández-Alvarez, Petra Frager, Konstantin Slobodnyuk, Natalia Plana, Angel R Nebreda, Manuel Palacin, Roger R Gomis, Christian Behrends, Antonio Zorzano
Regulation of death receptor signaling by the autophagy protein TP53INP2. The EMBO journal 38 (10) (2019)
Ana R Cortazar, Veronica Torrano, Natalia Martín-Martín, Alfredo Caro-Maldonado, Laura Camacho, Ivana Hermanova, Elizabeth Guruceaga, Luis Francisco Lorenzo-Martín, Ruben Caloto, Roger R Gomis, Iñigo Apaolaza, Victor Quesada, Jan Trka, Antonio Gomez-Muñoz, Silvestre Vincent, Xosé R Bustelo, Francisco J Planes, Ana María Aransay, Arkaitz Carracedo
CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets. Cancer research 78 (21) (2018)
Fernando Salvador, Roger R Gomis
CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors. EMBO molecular medicine 10 (6) (2018)
Sylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, Enrique J Arenas, Fernando Salvador, Jelena Urosevic, Cristina Figueras-Puig, Federico Rojo, Ivan Del Barco Barrantes, Juan Miguel Cejalvo, Marta Palafox, Marc Guiu, Antoni Berenguer Llergo, Aikaterini Symeonidi, Anna Bellmunt, Daniela Kalafatovic, Anna Arnal-Estapé, Esther Fernández, Barbara Müllauer, Rianne Groeneveld, Konstantin Slobodnyuk, Camille Stephan-Otto Attolini, Cristina Saura, Joaquín Arribas, Javier Cortes, Ana Rovira, Montse Muñoz, Ana Lluch, Violeta Serra, Joan Albanell, Aleix Prat, Angel R Nebreda, Salvador Aznar Benitah, Roger R Gomis
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer. Nature cell biology 20 (2) (2018)
Natalia Martín-Martín, Marco Piva, Jelena Urosevic, Paula Aldaz, James D Sutherland, Sonia Fernández-Ruiz, Leire Arreal, Verónica Torrano, Ana R Cortazar, Evarist Planet, Marc Guiu, Nina Radosevic-Robin, Stephane Garcia, Iratxe Macías, Fernando Salvador, Giacomo Domenici, Oscar M Rueda, Amaia Zabala-Letona, Amaia Arruabarrena-Aristorena, Patricia Zúñiga-García, Alfredo Caro-Maldonado, Lorea Valcárcel-Jiménez, Pilar Sánchez-Mosquera, Marta Varela-Rey, Maria Luz Martínez-Chantar, Juan Anguita, Yasir H Ibrahim, Maurizio Scaltriti, Charles H Lawrie, Ana M Aransay, Juan L Iovanna, Jose Baselga, Carlos Caldas, Rosa Barrio, Violeta Serra, Maria dM Vivanco, Ander Matheu, Roger R Gomis, Arkaitz Carracedo
Stratification and therapeutic potential of PML in metastatic breast cancer. Nature communications 7 (2016)

Roger R Gomis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Roger R Gomis